Developer docs
API playgroundTry for free, no card

Search company profiles

Bolt

Full company profile

uuid00006w5

Namestring
Bolt
Legal namestring
Bolt Threads, Inc.
Websiteurl
bolt-bslk.com
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Bolt Threads, Inc. was a privately-held biomaterials company founded in 2013 and headquartered in Foxboro, Massachusetts. The company developed two core products: Mylo, a vegan leather alternative made from mycelium (the root structure of mushrooms) grown via proprietary fermentation, and Vegan Silk, a synthetic spider silk protein produced through bioengineering. Bolt's go-to-market was partnership-driven enterprise licensing and co-development with premium fashion and athletic brands — including Stella McCartney, Hermès, Adidas, and Lenzing — targeting the luxury and sportswear segments with sustainable, cruelty-free material alternatives. Revenue mechanics centered on material licensing royalties and limited direct product sales; the most prominent commercial outcome was the Stella McCartney Mylo handbag, of which approximately 100 units were sold at £1,995 each.

Despite raising approximately $476 million across multiple funding rounds from 2012 through 2025 — including a $253 million Series C in September 2021 led by Baillie Gifford — Bolt Threads failed to achieve commercial viability. Total cumulative spending exceeded £160 million before the company paused Mylo production in July 2023. Historical revenue of approximately $3.14 million was dwarfed by a net loss of roughly $65.39 million, implying unsustainable unit economics (~$3 million in cost per bag produced). By 2026, the company's website explicitly states that "The Company is no longer operating," and correspondence routes to a bankruptcy/collection email address. Bolt Threads, Inc. is a distinct entity from Bolt Projects Holdings, Inc. (formerly NASDAQ:BSLK), a separately incorporated company that focuses on biomaterials for beauty and personal care and which itself received a Nasdaq delisting determination in December 2025.

Short descriptiontext

Bolt Threads, Inc. was a private biomaterials company that developed Mylo (mycelium-based vegan leather) and Vegan Silk (synthetic spider silk) for luxury and athletic brand partners including Stella McCartney, Hermès, and Adidas before ceasing operations in 2023.

Operating statusenum
Closed
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersEmeryville, United States
HQ citystring
Emeryville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
biomaterials manufacturing, mycelium leather alternative, synthetic spider silk, sustainable fashion materials, vegan leather production
Industry1 code
1Sewing Thread Manufacturing
CodeIMAOAAAHPrimaryYes
NAICS code1 code
  • Fiber, Yarn, and Thread Mills31311
SIC code2 codes
  • Apparel & Other Finishd Prods Of Fabrics & Similar Matl2300
  • Textile Mill Products2200
Product category
Biomaterials
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Material Licensing
TypeLicensing Royalties
Description

Licensing Mylo and Vegan Silk materials to fashion and luxury brands for incorporation into their products.

2Direct Product Sales
TypeOne Time License
Description

Direct sales of consumer products made from Mylo materials, including the Stella McCartney partnership where approximately 100 bags were sold at £1,995 each before production was paused.

Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Mylo
Description

Vegan mushroom leather alternative developed by Bolt Threads, made from mycelium grown in labs from renewable ingredients.

texintel.com
Core offering1 text field

Bolt Threads developed and manufactured bioengineered materials — specifically Mylo, a leather alternative grown from mycelium, and Vegan Silk, a lab-grown spider silk protein fiber — sold to apparel, luxury, and sportswear brands as sustainable replacements for animal-derived leather and silk. The company commercialized the materials through direct brand collaborations, co-developed products (e.g., Stella McCartney's Falabella bag, Adidas Stan Smith Mylo), and licensing of its proprietary bio-fabricated inputs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Approximately 100 Mylo bags sold at £1,995 each before production pause in July 2023
Product overview1 text field

Bolt was a biomaterials company that developed sustainable material alternatives for the fashion industry. The company operated two primary product lines: Mylo™ (a mushroom-based leather alternative made from mycelium) and Vegan Silk™ (a synthetic spider silk product). Both products were positioned as sustainable alternatives to conventional animal-derived materials. The company partnered with fashion brands including Stella McCartney, Hermès, H&M, Levi's, Patagonia, and Adidas to develop prototypes. Bolt ceased operations in July 2023.

Product and service2 records
1Mylo
CategoryBioengineered Leather Alternatives
2Vegan Silk
CategoryBioengineered Protein Fibers
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Flagship partnership where Stella McCartney created garments and accessories from Mylo mushroom leather. The partnership produced a limited edition handbag priced at £1,995, with approximately 100 units sold before production was paused in July 2023.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with the French luxury goods maker to explore and develop mycelium-based materials for potential use in Hermès products, leveraging their combined expertise in sustainable luxury goods.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with the German athletic wear company to develop and incorporate mycelium-based materials into sportswear and athletic footwear products.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Market position
Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors19 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bolt

Biomaterialsbolt-bslk.com

Bolt Threads, Inc. was a private biomaterials company that developed Mylo (mycelium-based vegan leather) and Vegan Silk (synthetic spider silk) for luxury and athletic brand partners including Stella McCartney, Hermès, and Adidas before ceasing operations in 2023.

What Bolt does

Bolt Threads, Inc. was a privately-held biomaterials company founded in 2013 and headquartered in Foxboro, Massachusetts. The company developed two core products: Mylo, a vegan leather alternative made from mycelium (the root structure of mushrooms) grown via proprietary fermentation, and Vegan Silk, a synthetic spider silk protein produced through bioengineering. Bolt's go-to-market was partnership-driven enterprise licensing and co-development with premium fashion and athletic brands — including Stella McCartney, Hermès, Adidas, and Lenzing — targeting the luxury and sportswear segments with sustainable, cruelty-free material alternatives. Revenue mechanics centered on material licensing royalties and limited direct product sales; the most prominent commercial outcome was the Stella McCartney Mylo handbag, of which approximately 100 units were sold at £1,995 each.

Despite raising approximately $476 million across multiple funding rounds from 2012 through 2025 — including a $253 million Series C in September 2021 led by Baillie Gifford — Bolt Threads failed to achieve commercial viability. Total cumulative spending exceeded £160 million before the company paused Mylo production in July 2023. Historical revenue of approximately $3.14 million was dwarfed by a net loss of roughly $65.39 million, implying unsustainable unit economics (~$3 million in cost per bag produced). By 2026, the company's website explicitly states that "The Company is no longer operating," and correspondence routes to a bankruptcy/collection email address. Bolt Threads, Inc. is a distinct entity from Bolt Projects Holdings, Inc. (formerly NASDAQ:BSLK), a separately incorporated company that focuses on biomaterials for beauty and personal care and which itself received a Nasdaq delisting determination in December 2025.

Bolt firmographics

Firmographics
Name
Bolt
Legal name
Bolt Threads, Inc.
Website
https://bolt-bslk.com
Company type
Private
Founded year
2013
Operating status
Closed
Headcount range
11–50 employees
Short description
Bolt Threads, Inc. was a private biomaterials company that developed Mylo (mycelium-based vegan leather) and Vegan Silk (synthetic spider silk) for luxury and athletic brand partners including Stella McCartney, Hermès, and Adidas before ceasing operations in 2023.
Ownership category
akta.pro rank

Bolt industry classification

Industry
Product category
Biomaterials
NAICS
Fiber, Yarn, and Thread Mills (31311)
SIC
Apparel & Other Finishd Prods Of Fabrics & Similar Matl (2300), Textile Mill Products (2200)
akta.pro primary industry
Sewing Thread Manufacturing (IMAOAAAH)

Keywords

  • Biomaterials manufacturing
  • Mycelium leather alternative
  • Synthetic spider silk
  • Sustainable fashion materials
  • Vegan leather production

Where Bolt is headquartered

Location

Headquarters

HQ city
Emeryville
HQ country
United States
HQ region
North America

Markets served

Bolt business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

  1. Material Licensing: Licensing Mylo and Vegan Silk materials to fashion and luxury brands for incorporation into their products.
  2. Direct Product Sales: Direct sales of consumer products made from Mylo materials, including the Stella McCartney partnership where approximately 100 bags were sold at £1,995 each before production was paused.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Bolt product offering

Product offering

Core offering

Bolt Threads developed and manufactured bioengineered materials — specifically Mylo, a leather alternative grown from mycelium, and Vegan Silk, a lab-grown spider silk protein fiber — sold to apparel, luxury, and sportswear brands as sustainable replacements for animal-derived leather and silk. The company commercialized the materials through direct brand collaborations, co-developed products (e.g., Stella McCartney's Falabella bag, Adidas Stan Smith Mylo), and licensing of its proprietary bio-fabricated inputs.

Product overview

Bolt was a biomaterials company that developed sustainable material alternatives for the fashion industry. The company operated two primary product lines: Mylo™ (a mushroom-based leather alternative made from mycelium) and Vegan Silk™ (a synthetic spider silk product). Both products were positioned as sustainable alternatives to conventional animal-derived materials. The company partnered with fashion brands including Stella McCartney, Hermès, H&M, Levi's, Patagonia, and Adidas to develop prototypes. Bolt ceased operations in July 2023.

Differentiator

Problem solved

Functional benefit

Brands

  • Mylo: Vegan mushroom leather alternative developed by Bolt Threads, made from mycelium grown in labs from renewable ingredients.

Products and services

  • Mylo
  • Vegan Silk

Quantifiable outcome

  • Approximately 100 Mylo bags sold at £1,995 each before production pause in July 2023

Companies that use Bolt

Customer profile

Named customers4 records

Segments2 records

Ideal customer profiles2 records

Bolt technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Bolt partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered flagship and core.

  • Stella McCartneyflagshipStrategic or Co-development PartnerFlagship partnership where Stella McCartney created garments and accessories from Mylo mushroom leather. The partnership produced a limited edition handbag priced at £1,995, with approximately 100 units sold before production was paused in July 2023.
  • HermèscoreStrategic or Co-development PartnerPartnership with the French luxury goods maker to explore and develop mycelium-based materials for potential use in Hermès products, leveraging their combined expertise in sustainable luxury goods.
  • AdidascoreStrategic or Co-development PartnerPartnership with the German athletic wear company to develop and incorporate mycelium-based materials into sportswear and athletic footwear products.

Scale indicators5 records

Recent moves7 records

Expansion highlights3 records

Bolt competitors and assessment

Company assessment

Market position

Competitive moat3 records

Key risks6 records

Key highlights4 records

Customer concentration

Bolt social profiles

Digital presence

Bolt financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bolt leadership team

Management profile

Number of profiles

Profiles6 records

Bolt funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors19 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bolt M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bolt

What does Bolt do?

Bolt Threads developed and manufactured bioengineered materials — specifically Mylo, a leather alternative grown from mycelium, and Vegan Silk, a lab-grown spider silk protein fiber — sold to apparel, luxury, and sportswear brands as sustainable replacements for animal-derived leather and silk. The company commercialized the materials through direct brand collaborations, co-developed products (e.g., Stella McCartney's Falabella bag, Adidas Stan Smith Mylo), and licensing of its proprietary bio-fabricated inputs.

Is Bolt a public or private company?

Bolt is a private company. It is classified as venture growth investor backed and is currently closed.

When was Bolt founded?

Bolt was founded in 2013. It employs 11 to 50 people.

Where is Bolt based?

Bolt is headquartered in Emeryville, United States, in the North America region.

How does Bolt make money?

Two revenue lines are on record. Material Licensing is the primary driver. The others are direct Product Sales.

Does Bolt have an API?

No public API is recorded for Bolt.

What industry is Bolt in?

Bolt's product category is Biomaterials. Its primary akta.pro industry code is IMAOAAAH, Sewing Thread Manufacturing. Its NAICS code is 31311 and its SIC code is 2300.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
American Banking and Market NewsReviewing Bolt Projects (NASDAQ:BSLK) and Aduro Clean Technologies (NASDAQ:ADUR)Aduro Clean Technologies and Bolt Projects are compared on dividends, valuation, institutional ownership, earnings, profitability, and analyst ratings. Aduro beats Bolt on 9 of 14 factors, with a consensus price target of $29.25 implying 138.19% upside, while Bolt's rating score is 1.00.PrtimesPlant Based Leather Market Set to Hit USD 1.2 Billion by 2034 at 5.6% CAGR – PR TimesThe global plant-based leather market is projected to grow from USD 775 million in 2026 to USD 1.2 billion by 2034, exhibiting a compound annual growth rate of 5.6%. This expansion is driven by increasing consumer demand for cruelty-free materials and tightening environmental regulations in key regions like the EU and US. Leading companies such as Bolt Threads and MycoWorks are advancing production technologies using mycelium and other plant fibers to meet rising adoption in fashion and automotive sectors.Defense WorldAnalyzing Fenbo (NASDAQ:FEBO) & Bolt Projects (NASDAQ:BSLK)This article provides a comparative analysis of two small-cap consumer staples companies listed on NASDAQ: Fenbo Holdings Limited and Bolt Projects Holdings, Inc. The comparison evaluates eight financial factors including earnings, analyst recommendations, institutional ownership, dividends, profitability, valuation, and risk metrics. Fenbo reports higher revenue of $17.11 million versus Bolt Projects' $3.14 million, while Bolt Projects shows significantly higher net losses at -$65.39 million compared to Fenbo's -$1.99 million.Defense WorldCritical Analysis: Bolt Projects (NASDAQ:BSLK) & Reborn Coffee (NASDAQ:REBN)This article presents a comparative analysis of two small-cap consumer staples companies listed on NASDAQ: Reborn Coffee and Bolt Projects. The analysis contrasts the two across ten factors including profitability, risk/volatility, analyst ratings, valuation, and institutional ownership. Reborn Coffee reports higher revenue of $5.93 million but negative net margins of -191.48%, while Bolt Projects shows steeper losses with -$65.39 million net income despite lower revenue of $3.14 million.Defense WorldReviewing Bolt Projects (NASDAQ:BSLK) and Unilever (NYSE:UL)This article is a comparative financial analysis comparing Bolt Projects (BSLK), a small material solutions company with $3.14 million in revenue, against Unilever (UL), a large consumer goods company with $57.13 billion in revenue, across 12 factors including profitability, analyst ratings, valuation, and institutional ownership. The analysis concludes that Unilever outperforms Bolt Projects on 11 of the 12 metrics compared. The article provides no reporting of a specific event, but rather presents market data and analyst sentiment indicating that institutional investors and analysts view Unilever as the more favourable investment compared to the loss-making Bolt Projects.SelvaneLab-Grown & Bio-Designed Fabrics: Future of LuxuryAn SELVANE editorial examines the rise of lab-grown, recycled, and bio-designed fabrics as the fashion industry pivots toward sustainable alternatives to conventional textiles. Key innovations include mycelium-based leathers from MycoWorks and Bolt Threads, which can be cultivated in under two weeks with up to 90% less water than traditional animal leather, alongside chemically recycled fibers like Renewcell's Circulose® that transform discarded textiles into new raw materials. The article highlights growing adoption by major brands including Hermès, Stella McCartney, H&M, Levi's, and Patagonia, positioning bio-designed materials as a viable path toward circular fashion.SelvaneLab-Grown & Bio-Designed Fabrics: Future of LuxuryThe fashion industry is undergoing a fundamental transformation with lab-grown, bio-designed, and recycled fabrics emerging as sustainable alternatives to traditional textiles, with mycelium-based leathers and engineered silks reducing environmental impacts by up to 90% in water usage and over 80% in greenhouse gas emissions. Companies like MycoWorks (Reishi™), Bolt Threads (Mylo™), Spiber (Brewed Protein™), Renewcell (Circulose®), and Infinited Fiber Company (Infinna™) are scaling these materials through partnerships with major fashion brands including Hermès, Stella McCartney, H&M, Levi's, and Patagonia. The global bio-designed fashion materials market is projected to reach $1.5 billion by 2028, though challenges around scalability, cost, and infrastructure remain significant hurdles for widespread adoption.IsitleatherThe Truth About Lab-Grown Leather and Bio MaterialsDespite over $1 billion invested in lab-grown and bio-based leather alternatives over the past decade, no commercial lab-grown leather products exist, with commercial timelines pushed from 2022-2023 to 2027-2030. The article details how Bolt Threads sold approximately 100 bags at £1,995 each before pausing operations in July 2023, representing roughly $3 million in cost per bag produced, and documents the failure of multiple luxury brand partnerships including Hermès, Adidas, and Stella McCartney for mycelium-based materials. Only cork leather has achieved genuine commercial viability among alternatives, while most other bio-leathers contain 50-90% polyurethane plastic despite plant-based marketing claims.Stock TitanBolt Projects to delist from Nasdaq, end SEC reportingBolt Projects Holdings, a developer of biomaterials for the beauty and personal care industry, announced that its Board of Directors has approved voluntary delisting of its common stock and warrants from Nasdaq and deregistration to terminate its SEC reporting obligations under the Securities Exchange Act. The company was previously found non-compliant with Nasdaq's minimum equity standard requirement, received a delisting determination letter on December 31, 2025, and its shares were suspended from Nasdaq on January 5, 2026, now trading on the OTCPK market under symbols BSLK and BSLKW. The formal delisting is expected to become effective on or about March 12, 2026, after which the company will file Form 15 to end its reporting obligations.Business Wire BlogBolt Projects Holdings Announces Delisting From Nasdaq and SEC DeregistrationBolt Projects Holdings, a developer of biomaterials for the beauty and personal care industry, has announced its Board approved voluntary delisting from Nasdaq and deregistration from the SEC following a delisting determination letter issued on December 31, 2025 due to noncompliance with the minimum equity standard. The company's common stock and warrants will officially delist on or about March 12, 2026, after which the company will file Form 15 to terminate its reporting obligations under the Exchange Act. The Board cited its financial and liquidity position alongside the expected Nasdaq Form 25 filing as key factors driving the accelerated delisting decision.